77.4 F
New York
Thursday, July 29, 2021

Trevena [NASDAQ: TRVN] Soar on Selection of TRV027in Global COVID-19 Trial

Must read

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Shares of Trevena, Inc. [NASDAQ: TRVN] skyrocketed more than 5 percent during the pre-market trading session of Wednesday. The strong performance of the firm indicated the positive reaction of its investors after it disclosed the positive news regarding TRV027.

Trevena disclosed that TRV027 has been chosen for addition in a worldwide, multi-site, adaptive, Phase II-Phase III study in COVID-19 sufferers. The study has been carried out and financed as part of REMAP-CAP. The main objective of the study is to assess cure with the ability to decrease mortality, ICU admission, and morbidity in critically sick sufferers with COVID-19.

Details of REMAP-CAP COVID-19 ACE2 RAS Modulation Domain

The study has introduced as “REMAP-CAP COVID-19 ACE2 RAS Modulation Domain”. Moreover, TRV027 is developed on Nobel Prize-winning technology. This is the greatest accomplishment of the firm. It will allow the firm to bring a new cure for the sufferers living with COVID-19 infection.

Earlier, it has been revealed that Imperial College London has been examined as an evidence-based study. Moreover, the recent findings of the Data Monitoring and Safety Committee (DMSC) also encourage the use of TRV027.

DMSC discovered that there were no safety concerns related to TRV027. Imperial College London contemplates covering its research in the near future. Furthermore, it is also encouraging the development of TRV027 into the REMAP-CAP COVID-19 RAS domain study.

More articles

Latest article

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...

Digital Realty [NYSE: DLR] and Brookfield Announces Joint Venture

Digital Realty Trust, Inc.   and Brookfield Infrastructure Partners L.P. and its institutional partners disclosed on Wednesday that they have launched a 50/50 joint...

Red Cat [NASDAQ: RCAT] Announces Acquisition of Teal Drones

Red Cat Holdings, Inc. has inked an agreement on Tuesday to buy Teal Drones in an all-stock transaction. This acquisition will add Teal...